2013-2028 Report on Global G-CSF Biosimilars Market by Player, Region, Type, Application and Sales Channel

Published: Aug, 2019 | Pages: 115 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global G-CSF Biosimilars market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for G-CSF Biosimilars from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the G-CSF Biosimilars market.

Leading players of G-CSF Biosimilars including:
    Pfizer
    Novartis
    Roche
    Merck & Co.
    Sanofi
    Johnson & Johnson
    Gilead Science
    GlaxoSmithKline
    AbbVie
    Amgen
    AstraZeneca
    Bayer

Market split by Type, can be divided into:
    Human Growth Hormone
    Erythropoietin
    Monoclonal Antibodies
    Insulin
    Interferon
    Granulocyte-Colony Stimulating Factor

Market split by Application, can be divided into:
    Blood Disorders
    Oncology Diseases
    Chronic And Autoimmune Diseases
    Growth Hormone Deficiencies

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America Brazil, Argentina, Colombia and Chile etc.)
    Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

 Table of Contents

Chapter 1 G-CSF Biosimilars Market Overview
    1.1 G-CSF Biosimilars Definition
    1.2 Global G-CSF Biosimilars Market Size Status and Outlook (2013-2028)
    1.3 Global G-CSF Biosimilars Market Size Comparison by Region (2013-2028)
    1.4 Global G-CSF Biosimilars Market Size Comparison by Type (2013-2028)
    1.5 Global G-CSF Biosimilars Market Size Comparison by Application (2013-2028)
    1.6 Global G-CSF Biosimilars Market Size Comparison by Sales Channel (2013-2028)
    1.7 G-CSF Biosimilars Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 G-CSF Biosimilars Market Segment Analysis by Player
    2.1 Global G-CSF Biosimilars Sales and Market Share by Player (2016-2018)
    2.2 Global G-CSF Biosimilars Revenue and Market Share by Player (2016-2018)
    2.3 Global G-CSF Biosimilars Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 G-CSF Biosimilars Market Segment Analysis by Type
    3.1 Global G-CSF Biosimilars Market by Type
        3.1.1 Human Growth Hormone
        3.1.2 Erythropoietin
        3.1.3 Monoclonal Antibodies
        3.1.4 Insulin
        3.1.5 Interferon
    3.2 Global G-CSF Biosimilars Sales and Market Share by Type (2013-2018)
    3.3 Global G-CSF Biosimilars Revenue and Market Share by Type (2013-2018)
    3.4 Global G-CSF Biosimilars Average Price by Type (2013-2018)
    3.5 Leading Players of G-CSF Biosimilars by Type in 2018
    3.6 Conclusion of Segment by Type
Chapter 4 G-CSF Biosimilars Market Segment Analysis by Application
    4.1 Global G-CSF Biosimilars Market by Application
        4.1.1 Blood Disorders
        4.1.2 Oncology Diseases
        4.1.3 Chronic And Autoimmune Diseases
        4.1.4 Growth Hormone Deficiencies
    4.2 Global G-CSF Biosimilars Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of G-CSF Biosimilars by Application in 2018
    4.4 Conclusion of Segment by Application
Chapter 5 G-CSF Biosimilars Market Segment Analysis by Sales Channel
    5.1 Global G-CSF Biosimilars Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global G-CSF Biosimilars Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of G-CSF Biosimilars by Sales Channel in 2018
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 G-CSF Biosimilars Market Segment Analysis by Region
    6.1 Global G-CSF Biosimilars Market Size and CAGR by Region (2013-2028)
    6.2 Global G-CSF Biosimilars Sales and Market Share by Region (2013-2018)
    6.3 Global G-CSF Biosimilars Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America G-CSF Biosimilars Market Share by Type
        6.4.3 North America G-CSF Biosimilars Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe G-CSF Biosimilars Market Share by Type
        6.5.3 Europe G-CSF Biosimilars Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific G-CSF Biosimilars Market Share by Type
        6.6.3 Asia-Pacific G-CSF Biosimilars Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America G-CSF Biosimilars Market Share by Type
        6.7.3 South America G-CSF Biosimilars Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa G-CSF Biosimilars Market Share by Type
        6.8.3 Middle East & Africa G-CSF Biosimilars Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading G-CSF Biosimilars Players
    7.1 Pfizer
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Novartis
    7.3 Roche
    7.4 Merck & Co.
    7.5 Sanofi
    7.6 Johnson & Johnson
    7.7 Gilead Science
    7.8 GlaxoSmithKline
    7.9 AbbVie
    7.10 Amgen
    7.11 AstraZeneca
    7.12 Bayer
Chapter 8 Upstream and Downstream Analysis of G-CSF Biosimilars
    8.1 Industrial Chain of G-CSF Biosimilars
    8.2 Upstream of G-CSF Biosimilars
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of G-CSF Biosimilars
        8.3.1 Leading Distributors/Dealers of G-CSF Biosimilars
        8.3.2 Leading Consumers of G-CSF Biosimilars
Chapter 9 Development Trend of G-CSF Biosimilars (2019-2028)
    9.1 Global G-CSF Biosimilars Market Size (Sales and Revenue) Forecast (2019-2028)
    9.2 Global G-CSF Biosimilars Market Size and CAGR Forecast by Region (2019-2028)
    9.3 Global G-CSF Biosimilars Market Size and CAGR Forecast by Type (2019-2028)
    9.4 Global G-CSF Biosimilars Market Size and CAGR Forecast by Application (2019-2028)
    9.5 Global G-CSF Biosimilars Market Size Forecast by Sales Channel (2019-2028)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

List of Tables and Figures

    Figure G-CSF Biosimilars Example
    Figure Global G-CSF Biosimilars Revenue (Million $) Status and Outlook (2013-2028)
    Figure Global G-CSF Biosimilars Revenue (Million $) Comparison by Region (2013-2028)
    Figure Global G-CSF Biosimilars Sales Comparison by Type (2013-2028)
    Figure Global G-CSF Biosimilars Sales Comparison by Application (2013-2028)
    Figure Global G-CSF Biosimilars Sales Comparison by Sales Channel (2013-2028)
    Table Global G-CSF Biosimilars Sales by Player (2016-2018)
    Table Global G-CSF Biosimilars Sales Market Share by Player (2016-2018)
    Figure Global G-CSF Biosimilars Sales Market Share by Player in 2018
    Table Global G-CSF Biosimilars Revenue (Million $) by Player (2016-2018)
    Table Global G-CSF Biosimilars Revenue Market Share by Player (2016-2018)
    Figure Global G-CSF Biosimilars Revenue Market Share by Player in 2018
    Table Global G-CSF Biosimilars Average Price by Player (2016-2018)
    Figure Global G-CSF Biosimilars Average Price by Player in 2018
    Figure Global G-CSF Biosimilars Players Competition Situation - Top 5 Players' Revenue Market Share in 2016
    Figure Global G-CSF Biosimilars Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
    Figure Example of Human Growth Hormone
    Figure Global Human Growth Hormone Sales and Growth Rate (2013-2018)
    Figure Example of Erythropoietin
    Figure Global Erythropoietin Sales and Growth Rate (2013-2018)
    Figure Example of Monoclonal Antibodies
    Figure Global Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Example of Insulin
    Figure Global Insulin Sales and Growth Rate (2013-2018)
    Figure Example of Interferon
    Figure Global Interferon Sales and Growth Rate (2013-2018)
    Table Global G-CSF Biosimilars Sales by Type (2013-2018)
    Table Global G-CSF Biosimilars Sales Market Share by Type (2013-2018)
    Figure Global G-CSF Biosimilars Sales Market Share by Type in 2018
    Table Global G-CSF Biosimilars Revenue (Million $) by Type (2013-2018)
    Table Global G-CSF Biosimilars Revenue Market Share by Type (2013-2018)
    Figure Global G-CSF Biosimilars Revenue Market Share by Type in 2018
    Table Global G-CSF Biosimilars Average Price by Type (2013-2018)
    Figure Global G-CSF Biosimilars Average Price by Type in 2018
    Table Leading Players of G-CSF Biosimilars by Type in 2018
    Figure Example of Blood Disorders
    Figure Global G-CSF Biosimilars for Blood Disorders Sales and Growth Rate (2013-2018)
    Figure Example of Oncology Diseases
    Figure Global G-CSF Biosimilars for Oncology Diseases Sales and Growth Rate (2013-2018)
    Figure Example of Chronic And Autoimmune Diseases
    Figure Global G-CSF Biosimilars for Chronic And Autoimmune Diseases Sales and Growth Rate (2013-2018)
    Figure Example of Growth Hormone Deficiencies
    Figure Global G-CSF Biosimilars for Growth Hormone Deficiencies Sales and Growth Rate (2013-2018)
    Table Global G-CSF Biosimilars Sales by Application (2013-2018)
    Table Global G-CSF Biosimilars Sales Market Share by Application (2013-2018)
    Figure Global G-CSF Biosimilars Sales Market Share by Application in 2018
    Table Leading Consumers of G-CSF Biosimilars by Application in 2018
    Figure Example of Direct Channel
    Figure Global G-CSF Biosimilars for Direct Channel Sales and Growth Rate (2013-2018)
    Figure Example of Distribution Channel
    Figure Global G-CSF Biosimilars for Distribution Channel Sales and Growth Rate (2013-2018)
    Table Global G-CSF Biosimilars Sales by Sales Channel (2013-2018)
    Table Global G-CSF Biosimilars Sales Market Share by Sales Channel (2013-2018)
    Figure Global G-CSF Biosimilars Sales Market Share by Sales Channel in 2018
    Table Leading Distributors/Dealers of G-CSF Biosimilars by Sales Channel in 2018
    Table Global G-CSF Biosimilars Market Size and CAGR by Region (2013-2028)
    Table Global G-CSF Biosimilars Sales by Region (2013-2018)
    Table Global G-CSF Biosimilars Sales Market Share by Region (2013-2018)
    Figure Global G-CSF Biosimilars Sales Market Share by Region in 2018
    Table Global G-CSF Biosimilars Revenue (Million $) by Region (2013-2018)
    Table Global G-CSF Biosimilars Revenue Market Share by Region (2013-2018)
    Figure Global G-CSF Biosimilars Revenue Market Share by Region in 2018
    Table North America G-CSF Biosimilars Sales by Country (2013-2018)
    Figure North America G-CSF Biosimilars Sales Market Share by Country (2013-2018)
    Table North America G-CSF Biosimilars Revenue by Country (2013-2018)
    Figure North America G-CSF Biosimilars Revenue Market Share by Country (2013-2018)
    Figure North America G-CSF Biosimilars Sales Market Share by Type in 2018
    Figure North America G-CSF Biosimilars Sales Market Share by Application in 2018
    Figure United States G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure United States G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Canada G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Canada G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Mexico G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Mexico G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Table Europe G-CSF Biosimilars Sales by Country (2013-2018)
    Figure Europe G-CSF Biosimilars Sales Market Share by Country (2013-2018)
    Table Europe G-CSF Biosimilars Revenue by Country (2013-2018)
    Figure Europe G-CSF Biosimilars Revenue Market Share by Country (2013-2018)
    Figure Europe G-CSF Biosimilars Sales Market Share by Type in 2018
    Figure Europe G-CSF Biosimilars Sales Market Share by Application in 2018
    Figure Germany G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Germany G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure UK G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure UK G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure France G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure France G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Italy G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Italy G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Russia G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Russia G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Spain G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Spain G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Table Asia-Pacific G-CSF Biosimilars Sales by Country (2013-2018)
    Figure Asia-Pacific G-CSF Biosimilars Sales Market Share by Country (2013-2018)
    Table Asia-Pacific G-CSF Biosimilars Revenue by Country (2013-2018)
    Figure Asia-Pacific G-CSF Biosimilars Revenue Market Share by Country (2013-2018)
    Figure Asia-Pacific G-CSF Biosimilars Sales Market Share by Type in 2018
    Figure Asia-Pacific G-CSF Biosimilars Sales Market Share by Application in 2018
    Figure China G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure China G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Japan G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Japan G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Korea G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Korea G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure India G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure India G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Southeast Asia G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Southeast Asia G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Australia G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Australia G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Table South America G-CSF Biosimilars Sales by Country (2013-2018)
    Figure South America G-CSF Biosimilars Sales Market Share by Country (2013-2018)
    Table South America G-CSF Biosimilars Revenue by Country (2013-2018)
    Figure South America G-CSF Biosimilars Revenue Market Share by Country (2013-2018)
    Figure South America G-CSF Biosimilars Sales Market Share by Type in 2018
    Figure South America G-CSF Biosimilars Sales Market Share by Application in 2018
    Figure Brazil G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Brazil G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Argentina G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Argentina G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Colombia G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Colombia G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Chile G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Chile G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Table Middle East & Africa G-CSF Biosimilars Sales by Country (2013-2018)
    Figure Middle East & Africa G-CSF Biosimilars Sales Market Share by Country (2013-2018)
    Table Middle East & Africa G-CSF Biosimilars Revenue by Country (2013-2018)
    Figure Middle East & Africa G-CSF Biosimilars Revenue Market Share by Country (2013-2018)
    Figure Middle East & Africa G-CSF Biosimilars Sales Market Share by Type in 2018
    Figure Middle East & Africa G-CSF Biosimilars Sales Market Share by Application in 2018
    Figure Egypt G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Egypt G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Saudi Arabia G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Saudi Arabia G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure South Africa G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure South Africa G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Nigeria G-CSF Biosimilars Sales and Growth Rate (2013-2018)
    Figure Nigeria G-CSF Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Table Company Snapshot of Pfizer
    Table G-CSF Biosimilars Introduction of Pfizer
    Table G-CSF Biosimilars Sales, Price, Revenue, Gross Margin and Market Share of Pfizer (2016-2018)
    Table Industrial Chain of G-CSF Biosimilars
    Table Manufacturing Cost Structure of G-CSF Biosimilars
    Table General Manufacturing Process of G-CSF Biosimilars
    Table Leading Distributors/Dealers of G-CSF Biosimilars
    Table Leading Consumers of G-CSF Biosimilars
    Figure Global G-CSF Biosimilars Sales and Growth Rate Forecast (2019-2028)
    Figure Global G-CSF Biosimilars Revenue and Growth Rate Forecast (2019-2028)
    Table Global G-CSF Biosimilars Market Size and CAGR Forecast by Region (2019-2028)
    Table Global G-CSF Biosimilars Market Size and CAGR Forecast by Type (2019-2028)
    Table Global G-CSF Biosimilars Market Size and CAGR Forecast by Application (2019-2028)
    Table Global G-CSF Biosimilars Market Size and CAGR Forecast by Sales Channel (2019-2028)

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.